ACRS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.40%

Insider Buying (Last 12 Months): $4,476,644.42

Insider Selling (Last 12 Months): $0.00

Aclaris Therapeutics Insider Trading History Chart

Aclaris Therapeutics Share Price & Price History

^$1.53

▼ -0.06 (-3.77%)

As of 03/31/2025 05:00 PM ET

Days: 30 | 90 | 365

Aclaris Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/19/2024	Anand Mehra	Director	Buy	666,666	$2.25	$1,499,998.50	710,030
7/30/2024	Braden Michael Leonard	Major Shareholder	Buy	173,730	$1.30	$225,849.00	13,776,421
7/22/2024	Braden Michael Leonard	Major Shareholder	Buy	17,716	$1.33	$23,562.28	13,602,691
7/18/2024	Braden Michael Leonard	Major Shareholder	Buy	130,317	$1.30	$169,412.10	13,578,286
7/5/2024	Braden Michael Leonard	Major Shareholder	Buy	123,017	$1.15	$141,469.55	13,447,969
7/3/2024	Braden Michael Leonard	Major Shareholder	Buy	143,288	$1.16	$166,214.08	13,324,952
7/1/2024	Braden Michael Leonard	Major Shareholder	Buy	107,434	$1.14	$122,474.76	13,095,572
6/27/2024	Braden Michael Leonard	Major Shareholder	Buy	235,000	$1.15	$270,250.00	11,787,134
6/17/2024	Braden Michael Leonard	Major Shareholder	Buy	150,000	$1.13	$169,500.00	11,502,134
6/13/2024	Braden Michael Leonard	Major Shareholder	Buy	528,621	$1.15	$607,914.15	11,007,134
6/11/2024	Braden Michael Leonard	Major Shareholder	Buy	1,000,000	$1.08	$1,080,000.00	10,395,934
10/23/2023	Joseph Monahan	Insider	Sell	6,000	$5.08	$30,480.00	129,724
8/28/2023	James Loerop	Insider	Buy	14,705	$6.80	$99,994.00	21,688
8/21/2023	Joseph Monahan	Insider	Sell	6,000	$7.32	$43,920.00	135,724
6/20/2023	Joseph Monahan	Insider	Sell	6,000	$10.28	$61,680.00	141,724
3/9/2023	Douglas J Manion	CEO	Buy	6,500	$7.74	$50,310.00	6,500
3/2/2023	Joseph Monahan	Insider	Sell	14,800	$12.37	$183,076.00	151,261
3/2/2023	Kevin Balthaser	CFO	Sell	1,000	$12.29	$12,290.00	4,650
3/2/2023	Neal Walker	Director	Sell	29,000	$12.37	$358,730.00	1,285,188
2/8/2023	James Loerop	Insider	Sell	4,267	$13.89	$59,268.63	6,983
1/3/2023	Neal Walker	Director	Sell	25,000	$15.25	$381,250.00	1,220,763
12/15/2022	Joseph Monahan	Insider	Sell	5,000	$15.88	$79,400.00	96,386
10/26/2022	Andrew N Schiff	Director	Sell	14,540	$17.00	$247,180.00	488,381
10/24/2022	Andrew N Schiff	Director	Sell	14,616	$17.01	$248,618.16	514,939
10/17/2022	Andrew N Schiff	Director	Sell	19,944	$16.05	$320,101.20	561,648
10/17/2022	Joseph Monahan	Insider	Sell	5,000	$15.98	$79,900.00	101,386
10/6/2022	Andrew N Schiff	Director	Sell	37,839	$16.54	$625,857.06	588,916
10/4/2022	Andrew N Schiff	Director	Sell	7,700	$16.01	$123,277.00	626,755
6/17/2022	Andrew N. Schiff	Director	Sell	19,565	$15.14	$296,214.10
4/25/2022	Neal Walker	CEO	Sell	20,000	$15.18	$303,600.00	1,245,763
4/21/2022	Neal Walker	CEO	Sell	25,000	$15.24	$381,000.00	1,290,763
4/18/2022	Joseph Monahan	Insider	Sell	30,000	$16.28	$488,400.00	106,386

See Full Table

SEC Filings (Institutional Ownership Changes) for Aclaris Therapeutics (NASDAQ:ACRS)

98.34% of Aclaris Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aclaris Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/27/2025	Jefferies Financial Group Inc.	40,700	$0.10M	0.0%	+253.9%	0.057%
2/18/2025	Alpine Global Management LLC	15,340	$38K	0.0%	N/A	0.021%
2/17/2025	Velan Capital Investment Management LP	27,000	$67K	0.1%	N/A	0.038%
2/17/2025	Squarepoint Ops LLC	292,892	$0.73M	0.0%	+108.3%	0.410%
2/17/2025	Two Sigma Advisers LP	977,400	$2.42M	0.0%	-24.9%	1.368%
2/17/2025	Two Sigma Investments LP	839,270	$2.08M	0.0%	-7.6%	1.175%
2/17/2025	Stonepine Capital Management LLC	663,405	$1.65M	1.3%	-73.0%	0.929%
2/17/2025	Man Group plc	53,534	$0.13M	0.0%	N/A	0.075%
2/17/2025	OMERS ADMINISTRATION Corp	54,400	$0.14M	0.0%	N/A	0.076%
2/17/2025	Millennium Management LLC	1,959,047	$4.86M	0.0%	-34.8%	2.743%
2/17/2025	Jacobs Levy Equity Management Inc.	576,042	$1.43M	0.0%	-37.1%	0.806%
2/17/2025	Janus Henderson Group PLC	2,799,759	$6.99M	0.0%	N/A	3.920%
2/17/2025	Jefferies Financial Group Inc.	40,700	$0.10M	0.0%	+253.9%	0.057%
2/17/2025	Graham Capital Management L.P.	14,172	$35K	0.0%	N/A	0.020%
2/17/2025	D. E. Shaw & Co. Inc.	3,293,625	$8.17M	0.0%	-2.3%	4.611%
2/17/2025	Cubist Systematic Strategies LLC	256,092	$0.64M	0.0%	+3,573.7%	0.359%
2/17/2025	Bridgeway Capital Management LLC	281,119	$0.70M	0.0%	+41.2%	0.394%
2/17/2025	Cantor Fitzgerald L. P.	100,000	$0.25M	0.0%	N/A	0.140%
2/17/2025	Bank of America Corp DE	205,465	$0.51M	0.0%	+2,246.3%	0.288%
2/17/2025	683 Capital Management LLC	217,265	$0.54M	0.0%	N/A	0.304%
2/14/2025	RA Capital Management L.P.	4,666,667	$11.57M	0.2%	N/A	6.533%
2/14/2025	Monashee Investment Management LLC	888,888	$2.20M	0.3%	N/A	1.244%
2/14/2025	Samsara BioCapital LLC	2,385,060	$5.92M	0.8%	+242.6%	3.339%
2/14/2025	Schonfeld Strategic Advisors LLC	131,895	$0.33M	0.0%	N/A	0.185%
2/14/2025	Northern Trust Corp	175,175	$0.43M	0.0%	+37.7%	0.245%
2/14/2025	Decheng Capital LLC	2,266,667	$5.62M	1.2%	N/A	3.173%
2/14/2025	Boothbay Fund Management LLC	112,484	$0.28M	0.0%	N/A	0.157%
2/14/2025	Adage Capital Partners GP L.L.C.	9,627,304	$23.88M	0.0%	N/A	13.478%
2/14/2025	Price T Rowe Associates Inc. MD	123,100	$0.31M	0.0%	-11.7%	0.172%
2/14/2025	Alpine Global Management LLC	15,340	$38K	0.0%	N/A	0.021%
2/14/2025	Rock Springs Capital Management LP	6,204,309	$15.39M	0.6%	+125.3%	8.686%
2/14/2025	Vivo Capital LLC	8,888,888	$22.04M	2.5%	N/A	12.444%
2/14/2025	Dimensional Fund Advisors LP	239,595	$0.59M	0.0%	+211.9%	0.335%
2/13/2025	Marshall Wace LLP	2,634,065	$6.53M	0.0%	N/A	3.688%
2/13/2025	Walleye Capital LLC	718,897	$1.78M	0.0%	N/A	1.006%
2/13/2025	XTX Topco Ltd	44,685	$0.11M	0.0%	N/A	0.063%
2/13/2025	Mariner LLC	37,774	$94K	0.0%	-21.5%	0.053%
2/13/2025	Barclays PLC	15,201	$38K	0.0%	-25.5%	0.021%
2/13/2025	Raymond James Financial Inc.	154,351	$0.38M	0.0%	N/A	0.216%
2/13/2025	Renaissance Technologies LLC	850,519	$2.11M	0.0%	-38.0%	1.191%
2/13/2025	Invesco Ltd.	11,215	$28K	0.0%	N/A	0.016%
2/12/2025	Aldebaran Capital LLC	1,016,958	$2.52M	2.4%	-2.5%	1.424%
2/12/2025	ExodusPoint Capital Management LP	10,637	$26K	0.0%	N/A	0.015%
2/12/2025	Geode Capital Management LLC	789,597	$1.96M	0.0%	-6.7%	1.105%
2/12/2025	JPMorgan Chase & Co.	88,320	$0.22M	0.0%	+942.0%	0.124%
2/10/2025	Commonwealth Equity Services LLC	14,694	$36K	0.0%	N/A	0.021%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	908,819	$2.25M	0.0%	+173.4%	1.272%
2/7/2025	HighTower Advisors LLC	262,948	$0.65M	0.0%	-14.0%	0.368%
2/6/2025	Raymond James Financial Inc.	154,351	$0.38M	0.0%	N/A	0.216%
2/6/2025	Charles Schwab Investment Management Inc.	33,079	$82K	0.0%	N/A	0.046%
1/29/2025	Peapod Lane Capital LLC	404,452	$1M	1.0%	N/A	0.566%
1/14/2025	Marquette Asset Management LLC	57,911	$0.14M	0.0%	-31.0%	0.081%
1/14/2025	Assenagon Asset Management S.A.	397,362	$0.99M	0.0%	+113.9%	0.556%
11/16/2024	Geode Capital Management LLC	846,446	$0.97M	0.0%	+9.3%	1.185%
11/15/2024	Jane Street Group LLC	82,727	$95K	0.0%	-75.3%	0.116%
11/15/2024	State Street Corp	188,721	$0.22M	0.0%	-4.0%	0.264%
11/15/2024	Jacobs Levy Equity Management Inc.	915,509	$1.05M	0.0%	N/A	1.282%
11/15/2024	HighTower Advisors LLC	305,814	$0.35M	0.0%	-2.2%	0.428%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	52,052	$60K	0.0%	-51.8%	0.073%
11/14/2024	Stonepine Capital Management LLC	2,458,873	$2.83M	1.8%	+27.6%	3.442%
11/13/2024	FMR LLC	545,972	$0.63M	0.0%	-20.8%	0.764%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	332,406	$0.38M	0.0%	+187.6%	0.466%
11/5/2024	BML Capital Management LLC	14,250,000	$16.39M	9.6%	+9.7%	19.973%
11/5/2024	GSA Capital Partners LLP	255,032	$0.29M	0.0%	-24.3%	0.357%
10/23/2024	Assenagon Asset Management S.A.	185,777	$0.21M	0.0%	N/A	0.261%
10/8/2024	Trium Capital LLP	1,912,990	$2.20M	0.6%	+1.1%	2.684%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	107,929	$0.12M	0.0%	N/A	0.151%
8/21/2024	Stonepine Capital Management LLC	1,927,446	$2.12M	1.9%	N/A	2.705%
8/15/2024	Millennium Management LLC	3,336,850	$3.67M	0.0%	+1.9%	4.682%
8/15/2024	AQR Capital Management LLC	386,177	$0.43M	0.0%	-36.9%	0.542%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	107,929	$0.12M	0.0%	N/A	0.151%
8/12/2024	XTX Topco Ltd	24,452	$27K	0.0%	-80.1%	0.034%
8/9/2024	Renaissance Technologies LLC	922,200	$1.01M	0.0%	-44.9%	1.294%
8/9/2024	Dimensional Fund Advisors LP	76,759	$84K	0.0%	-13.8%	0.108%
8/6/2024	Trium Capital LLP	1,892,050	$2.08M	0.3%	N/A	2.655%
8/6/2024	Acadian Asset Management LLC	1,913,449	$2.10M	0.0%	-10.4%	2.685%
8/1/2024	Rhumbline Advisers	42,005	$46K	0.0%	-56.8%	0.059%
7/30/2024	Deuterium Capital Management LLC	72,091	$79K	0.1%	-9.9%	0.101%
5/16/2024	Bain Capital Life Sciences Investors LLC	3,000,000	$3.72M	0.3%	-14.3%	4.210%
5/10/2024	Acadian Asset Management LLC	2,135,367	$2.65M	0.0%	-9.2%	2.996%
5/10/2024	Vanguard Group Inc.	4,929,775	$6.11M	0.0%	+4.4%	6.918%
5/8/2024	Russell Investments Group Ltd.	62,772	$78K	0.0%	+5,265.1%	0.088%
5/7/2024	SG Americas Securities LLC	32,843	$41K	0.0%	+69.5%	0.046%
5/7/2024	Marquette Asset Management LLC	83,979	$0.10M	0.0%	N/A	0.118%
5/7/2024	Deuterium Capital Management LLC	79,993	$99K	0.2%	N/A	0.112%
5/3/2024	GSA Capital Partners LLP	679,137	$0.84M	0.1%	-57.2%	0.953%
5/1/2024	BNP Paribas Financial Markets	241,101	$0.30M	0.0%	+10.9%	0.338%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	31,552	$39K	0.0%	N/A	0.044%
4/23/2024	BML Capital Management LLC	9,395,934	$11.65M	7.7%	+1,338.7%	13.248%
2/15/2024	Octagon Capital Advisors LP	100,000	$0.11M	0.0%	N/A	0.141%
2/13/2024	Bain Capital Life Sciences Investors LLC	3,500,000	$3.68M	0.4%	+2.9%	4.944%
2/7/2024	Monaco Asset Management SAM	979,399	$1.03M	0.3%	N/A	1.384%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	43,784	$46K	0.0%	+115.5%	0.062%
1/30/2024	BML Capital Management LLC	653,107	$0.69M	0.5%	N/A	0.923%
1/30/2024	Strs Ohio	193,000	$0.20M	0.0%	+256.7%	0.273%
1/30/2024	Vontobel Holding Ltd.	30,268	$32K	0.0%	+128.8%	0.043%
12/18/2023	Vanguard Group Inc.	3,363,046	$23.04M	0.0%	+1.0%	4.751%
12/6/2023	Citigroup Inc.	11,864	$81K	0.0%	-60.6%	0.017%
12/1/2023	Wellington Management Group LLP	6,979,844	$47.81M	0.0%	-8.6%	9.860%
11/14/2023	Blackstone Inc.	1,261,425	$8.64M	0.0%	+9,578.7%	1.782%

Data available starting January 2016

See Full Table

Aclaris Therapeutics, Inc. a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. The company operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment provides laboratory services. It develops Zunsemetinib (ATI-450), an MK2 inhibitor which is under Phase 1b/2 trials for the treatment of metastatic breast and pancreatic cancer; ATI-1777, a soft JAK 1/3 inhibitor, completed Phase 2b trails for the treatment of moderate to severe atopic dermatitis and other dermatologic conditions; and ATI-2138, an oral covalent inhibitor of ITK and JAK3 inhibitor under Phase 1 trials as a treatment for T cell-mediated autoimmune diseases. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

Today's Range

Now: $1.53

$1.47

$1.57

50 Day Range

MA: $2.08

$1.55

$2.60

52 Week Range

Now: $1.53

$0.95

$5.17

Volume

512,536 shs

Average Volume

1,172,161 shs

Market Capitalization

$165.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.48

Who are the company insiders with the largest holdings of Aclaris Therapeutics?: Aclaris Therapeutics' top insider shareholders include:
Braden Michael Leonard (Major Shareholder)
Anand Mehra (Director)
Joseph Monahan (Insider)
James Loerop (Insider)
Learn More about top insider investors at Aclaris Therapeutics.
Who are the major institutional investors of Aclaris Therapeutics?: Aclaris Therapeutics' top institutional investors include:
Adage Capital Partners GP L.L.C. — 13.48%
Vivo Capital LLC — 12.44%
Rock Springs Capital Management LP — 8.69%
RA Capital Management L.P. — 6.53%
D. E. Shaw & Co. Inc. — 4.61%
Janus Henderson Group PLC — 3.92%
Learn More about top institutional investors of Aclaris Therapeutics stock.
Which major investors are selling Aclaris Therapeutics stock?: Within the last quarter, ACRS stock was sold by these institutional investors:
Stonepine Capital Management LLC
Millennium Management LLC
Renaissance Technologies LLC
Jacobs Levy Equity Management Inc.
Two Sigma Advisers LP
D. E. Shaw & Co. Inc.
Two Sigma Investments LP
Geode Capital Management LLC
Which major investors are buying Aclaris Therapeutics stock?: During the previous quarter, ACRS stock was purchased by institutional investors including:
Adage Capital Partners GP L.L.C.
Vivo Capital LLC
RA Capital Management L.P.
Rock Springs Capital Management LP
Janus Henderson Group PLC
Marshall Wace LLP
Decheng Capital LLC
Samsara BioCapital LLC
During the previous year, these company insiders have bought Aclaris Therapeutics stock:
Braden Michael Leonard (Major Shareholder)
Anand Mehra (Director)
Joseph Monahan (Insider)
Learn More investors buying Aclaris Therapeutics stock.